BX-795

CHF 78.00
In stock
SYN-1026-M0011 mgCHF 78.00
SYN-1026-M0055 mgCHF 120.00
SYN-1026-M01010 mgCHF 162.00
SYN-1026-M05050 mgCHF 646.00
SYN-1026-M100100 mgCHF 1'101.00
 
More Information
Product Details
Synonyms BX795
Product Type Chemical
Properties
Formula C23H26IN7O2S
MW 591.5
CAS 702675-74-9
Purity Chemicals ≥95%
Appearance Solid.
Solubility Soluble in DMSO or ethanol.
Declaration Manufactured by SynKinase.
Other Product Data Target: PDK1 | Kinase Group: AGC | Substrate: Serine-Threonine

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.
InChi Key VAVXGGRQQJZYBL-UHFFFAOYSA-N
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
BX795 was initially developed as a PDK1 inhibitor (direct competitive inhibitor IC(50) 11nM for PDK1) and has been shown to be a potent and relatively specific inhibitor of TBK1 and IKK-ε. It blocks the phosphorylation, nuclear translocation, and transcriptional activity of interferon regulatory factor 3. BX795 also is a potent inhibitor of cell growth of multiple cancer cell lines with IC(50) values ranging from submicromolar amounts (0.368µM to greater than 450µM.
Product References
  1. Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1: R.I. Feldmann, et al.; J. Biol. Chem. 280, 19867 (2005)
  2. The selectivity of protein kinase inhibitors: a further update: J. Bain, et al.; Biochem. J. 408, 297 (2007)
  3. Use of the pharmacological inhibitor BX795 to study the regulation and physiological roles of TBK1 and IkappaB kinase epsilon: a distinct upstream kinase mediates Ser-172 phosphorylation and activation: K. Clark, J. Biol. Chem. 284, 14136 (2009)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.